Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

REPLY: Is There an Intramyocardial "Purkinje" System in the Heart?

JACC. Clinical electrophysiology·2025

Same author

Healthspan-lifespan gap differs in magnitude and disease contribution across world regions.

Communications medicine·2025

Same author

MYL4 Identifies Intramural Anatomy of Purkinje Fibers in Human Hearts.

JACC. Clinical electrophysiology·2025

Same author

Maturation of human induced pluripotent stem cell-derived cardiomyocytes promoted by Brachyury priming.

Scientific reports·2025

Same author

Therapeutic effects of platelet-derived extracellular vesicles on viral myocarditis correlate with biomolecular content.

Frontiers in immunology·2025

Same author

Artificial intelligence powers regenerative medicine into predictive realm.

Regenerative medicine·2024

Search research articles

Related Experiment Video

Updated: Mar 23, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Stem cell therapy for heart failure: Ensuring regenerative proficiency.

Andre Terzic¹, Atta Behfar²

¹Center for Regenerative Medicine, Mayo Clinic, Rochester, MN; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN.

Trends in Cardiovascular Medicine

|March 30, 2016

Summary

Patient-derived stem cells show varied effectiveness in heart repair, hindering widespread use. New methods like cardiopoiesis aim to standardize stem cell potency for reliable regenerative therapies in heart failure.

Keywords:

Cardiopoiesis Cardiopoietic stem cell Cardiovascular disease Clinical trial Clinomics Epidemic Health care Myocardial infarction Next generation Quality Regenerative medicine System

More Related Videos

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

Related Experiment Videos

Last Updated: Mar 23, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

Area of Science:

Regenerative Medicine
Cardiovascular Biology
Stem Cell Therapy

Background:

Patient-derived stem cells offer regenerative potential but exhibit variable cardiac reparative capacity.
This heterogeneity leads to unpredictable therapeutic outcomes and impedes clinical adoption of stem cell therapies.
Standardized methods to certify the regenerative potency of biotherapies are crucial for clinical translation.

Purpose of the Study:

To introduce and evaluate cardiopoiesis-mediated lineage specification as a method to ensure consistent regenerative performance of stem cells.
To leverage clinomics and analyze variant cytoreparative performance in clinical trials.
To inform the development of cardio-regenerative quality systems by mapping pathways distinguishing regenerative from non-regenerative states.

Main Methods:

Cardiopoiesis-mediated lineage specification was developed to standardize stem cell regenerative potential.
Analysis of cytoreparative performance in clinical trials using a clinomics approach.
Pre-clinical and early clinical studies were conducted to assess safety and efficacy.

Main Results:

Cardiopoiesis has been successfully tested in pre-clinical and early clinical settings.
The safety and efficacy of the cardiopoietic stem cell phenotype are currently undergoing validation.
This approach provides a pathway to map critical factors influencing stem cell regenerative capacity.

Conclusions:

Cardiopoiesis-mediated lineage specification represents a promising strategy to ensure consistent stem cell potency for regenerative medicine.
Ongoing pivotal trials are validating this approach for treating chronic ischemic cardiomyopathy.
This methodology holds the potential to establish a next-generation regenerative solution for heart failure.